Drug intelligence / Profile preview

temporin L

Development stage
Preclinical
Lead developer
Sapienza University of Rome
Modality
Peptides
Administration
Intraperitoneal
01

Overview

Temporin L is a 13-amino acid antimicrobial peptide (AMP) originally isolated from the skin secretions of the European red frog, *Rana temporaria*. As a member of the temporin family, it is characterized by its small size, cationic nature, and amphipathic alpha-helical structure. Its primary mechanism of action involves the disruption of cell membranes through pore formation or a detergent-like effect, which leads to rapid cell lysis. While traditionally studied for its broad-spectrum antibacterial and antifungal properties, recent research has highlighted its potential as an antineoplastic agent. Specifically, Temporin L has shown significant in vitro anti-proliferative activity against marginal zone lymphoma (MZL) cell lines, maintaining efficacy even in models resistant to standard targeted therapies such as BTK, PI3K, and BCL2 inhibitors. It is currently being investigated by researchers at institutions including the Institute of Oncology Research and Sapienza University of Rome as a scaffold for developing novel lymphoma treatments.

Other names
Temporin-L
02

Targets

PM (Mammalian cell plasma membrane lipid bilayer)Microbial cytoplasmic membrane lipid bilayer

Beyond the preview

Go deeper on temporin L.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on temporin L.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call